Xue et al. (2019) indicated as an anti-inflammatory drug, chrysophanol has a protective effect on heart damage induced by diabetes, suggesting that this drug may attenuate inflammatory responses through upregulation of SIRT1, resulting in downregulation of the HMGB1/NF-κB pathway. Here, HMGB1 is linked to diabetes mellitus.